Semin Oncol. 2002 Dec;29(6):546-51.

Complementary and alternative medicine research: a National Cancer Institute perspective.

Source

Office of Cancer Complementary and Alternative Medicine, National Cancer Institute, National Institutes of Health, Executive Plaza North, Suite 102, Bethesda, MD 20892, USA.

Abstract

The widespread use of a variety of nutritional, psychological and natural medical approaches, collectively termed complementary and alternative medicine (CAM), has been well documented. Recent surveys demonstrate that between 9% and 91% of US cancer patients use CAM therapies at some time after their diagnosis. Despite their extensive use, there is a paucity of data available to indicate whether these practices are efficacious and safe. The National Cancer Institute (NCI) is implementing programs to increase the amount and quality of cancer CAM research, support the production of high-quality CAM cancer information, and facilitate the dialog between CAM practitioners and cancer researchers.

PMID:: 12516037; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

MeSH Terms

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Related citations

Review The National Cancer Institute's perspective and agenda for promoting awareness and research on alternative therapies for cancer. [J Altern Complement Med. 2002]
Review The National Cancer Institute's perspective and agenda for promoting awareness and research on alternative therapies for cancer.
White JD. J Altern Complement Med. 2002 Oct; 8(5):545-50.
Use of complementary medicine by adult patients participating in cancer clinical trials. [Oncol Nurs Forum. 2000]
Use of complementary medicine by adult patients participating in cancer clinical trials.
Sparber A, Bauer L, Curt G, Eisenberg D, Levin T, Parks S, Steinberg SM, Wootton J. Oncol Nurs Forum. 2000 May; 27(4):623-30.
Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience. [J Clin Oncol. 2005]
Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
Buchanan DR, White JD, O'Mara AM, Kelaghan JW, Smith WB, Minasian LM. J Clin Oncol. 2005 Sep 20; 23(27):6682-9.
Review New opportunities and proven approaches in complementary and alternative medicine research at the National Institutes of Health. [J Altern Complement Med. 2001]
Review New opportunities and proven approaches in complementary and alternative medicine research at the National Institutes of Health.
Harlan WR Jr. J Altern Complement Med. 2001; 7 Suppl 1:S53-9.
The role of rigorous scientific evaluation in the use and practice of complementary and alternative medicine. [J Am Coll Radiol. 2009]
The role of rigorous scientific evaluation in the use and practice of complementary and alternative medicine.
Kantor M. J Am Coll Radiol. 2009 Apr; 6(4):254-62.

See reviews... See all...

Cited by 3 PubMed Central articles

The prospects of vitamin C in cancer therapy. [Immune Netw. 2009]
The prospects of vitamin C in cancer therapy.
Lee WJ. Immune Netw. 2009 Oct; 9(5):147-52. Epub 2009 Oct 30.
Association of complementary and alternative medicine use with highly active antiretroviral therapy initiation. [Altern Ther Health Med. 2008]
Association of complementary and alternative medicine use with highly active antiretroviral therapy initiation.
Merenstein D, Yang Y, Schneider MF, Goparaju L, Weber K, Sharma A, Levine AM, Sharp GB, Gandhi M, Liu C. Altern Ther Health Med. 2008 Sep-Oct; 14(5):18-22.
Intravenously administered vitamin C as cancer therapy: three cases. [CMAJ. 2006]
Intravenously administered vitamin C as cancer therapy: three cases.
Padayatty SJ, Riordan HD, Hewitt SM, Katz A, Hoffer LJ, Levine M. CMAJ. 2006 Mar 28; 174(7):937-42.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Complementary and alternative medicine research: a National Cancer Institute per...
Complementary and alternative medicine research: a National Cancer Institute perspective.
Semin Oncol. 2002 Dec ;29(6):546-51.

PubMed
Quantification of human chemokine production in TLR-stimulated and antigen-speci...
Quantification of human chemokine production in TLR-stimulated and antigen-specific recall responses.
Methods Mol Med. 2008 ;138:121-31.

PubMed
MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation o...
MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts.
Mol Cell Biol. 2002 Apr ;22(8):2871-81.

PubMed
Retinoic acid in the immune system.
Retinoic acid in the immune system.
Ann N Y Acad Sci. 2008 Nov ;1143:170-87.

PubMed
Developmental- and differentiation-specific patterns of human gamma- and beta-gl...
Developmental- and differentiation-specific patterns of human gamma- and beta-globin promoter DNA methylation.
Blood. 2007 Aug 15 ;110(4):1343-52. Epub 2007 Apr 24 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: